Citation: W. Jager et al., GENISTEIN METABOLISM IN LIVER-MICROSOMES OF WISTAR AND MUTANT TR--RATS, Research communications in molecular pathology and pharmacology, 100(1), 1998, pp. 105-116
Authors:
HABERL I
SWATONEK H
SCHAUFLER K
ULSPERGER E
WENZL E
THEYER G
HAMILTON G
THALHAMMER T
Citation: I. Haberl et al., P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE IS MODULATED BY PRETREATMENT WITH CHEMOSENSITIZERS IN HCT-8 CARCINOMA-CELLS IN-VITRO, International journal of oncology, 12(5), 1998, pp. 1137-1142
Authors:
JAGER W
PLATZER P
HERZOG W
THALHAMMER T
HABERL I
HAMILTON G
Citation: W. Jager et al., FORMATION OF A NOVEL TOPOTECAN METABOLITE IN THE HORMONE-INDEPENDENT HUMAN PROSTATE CARCINOMA CELL-LINES DU-145 AND PC3, Annals of oncology, 9, 1998, pp. 224-224
Authors:
KASHANI M
STEINER G
HAITEL A
SCHAUFLER K
THALHAMMER T
AMANN G
KRAMER G
MARBERGER M
SCHOLLER A
Citation: M. Kashani et al., EXPRESSION OF THE ARYL-HYDROCARBON RECEPTOR (AHR) AND THE ARYL-HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR (ARNT) IN FETAL, BENIGN HYPERPLASTIC, AND MALIGNANT PROSTATE, The Prostate, 37(2), 1998, pp. 98-108
Authors:
PLATZER P
SCHADEN S
THALHAMMER T
HAMILTON G
ROSENBERG B
SILGONER I
JAGER W
Citation: P. Platzer et al., BIOTRANSFORMATION OF TOPOTECAN IN THE ISOLATED-PERFUSED RAT-LIVER - IDENTIFICATION OF 3 NOVEL METABOLITES, Anticancer research, 18(4A), 1998, pp. 2695-2700
Authors:
PLATZER P
HERZOG W
THALHAMMER T
HAMILTON G
HABERL I
JAGER W
Citation: P. Platzer et al., FORMATION OF A NOVEL TOPOTECAN METABOLITE IN THE HORMONE-INDEPENDENT HUMAN PROSTATE CARCINOMA CELL-LINES DU-145 AND PC-3, Anticancer research, 18(4A), 1998, pp. 2737-2741
Authors:
JAGER W
ZEMBSCH B
WOLSCHANN P
PITTENAUER E
SENDEROWICZ AM
SAUSVILLE EA
SEDLACEK HH
GRAF J
THALHAMMER T
Citation: W. Jager et al., METABOLISM OF THE ANTICANCER DRUG FLAVOPIRIDOL, A NEW INHIBITOR OF CYCLIN-DEPENDENT KINASES, IN RAT-LIVER, Life sciences, 62(20), 1998, pp. 1861-1873
Authors:
VIELNASCHER E
ROMANOVA D
NOVOTNY L
SZEKERES T
ELFORT HL
THALHAMMER T
JAGER W
Citation: E. Vielnascher et al., SIMULTANEOUS DETERMINATION OF THE NEW ANTICANCER AGENT AMIDOX AND ITSMETABOLITES IN RAT BILE AND PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 696(2), 1997, pp. 267-274
Authors:
JAGER W
WINTER O
HALPER B
SALAMON A
SARTORI M
GAJDZIK L
HAMILTON G
THEYER G
GRAF J
THALHAMMER T
Citation: W. Jager et al., MODULATION OF LIVER CANALICULAR TRANSPORT PROCESSES BY THE TYROSINE-KINASE INHIBITOR GENISTEIN - IMPLICATIONS OF GENISTEIN METABOLISM IN THE RAT, Hepatology, 26(6), 1997, pp. 1467-1476
Authors:
SCHOLLER A
SCHAUFLER K
HERZOG W
KASHANI M
GROBL M
MARBERGER M
GRAF J
STEINER G
THALHAMMER T
Citation: A. Scholler et al., DIOXIN RECEPTOR-DEPENDENT GENE-EXPRESSION IN HUMAN PROSTATE-CANCER CELLS AND PRIMARY EPITHELIAL CULTURES, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 46-46
Authors:
THALHAMMER T
BAKOS S
DOPPLINGER C
BOTZNITULESCU G
PENNER E
Citation: T. Thalhammer et al., AUTOANTIBODIES AGAINST MICROSOMAL-ENZYMES (LKM) IN PATIENTS WITH LIVER-DISEASES, The FASEB journal, 10(6), 1996, pp. 23-23
Authors:
PENNER E
THALHAMMER T
BAKOS S
BOLTZNITULESCU G
WICK G
Citation: E. Penner et al., AUTOANTIBODIES TO A NOVEL MICROSOMAL ANTIGEN IN CANDIDIASIS-ENDOCRINOPATHY SYNDROME-ASSOCIATED WITH AUTOIMMUNE HEPATITIS, The FASEB journal, 10(6), 1996, pp. 24-24
Authors:
SALAMON A
SARTORI M
HALPER B
JAEGER W
BOLTZNITULESCU G
THALHAMMER T
Citation: A. Salamon et al., IN-VITRO METABOLISM OF GENISTEIN IN LIVER-MICROSOMES OF CONTROL AND MUTANT TR(-)-RATS, The FASEB journal, 10(3), 1996, pp. 1013-1013
Authors:
CONSENTINI EP
HAMILTON G
RADERER M
BISCHOF G
ZACHERL J
REIGLER M
HUBSCH P
MULLER C
SCHEITHAUER W
THALHAMMER T
WENZL E
Citation: Ep. Consentini et al., MULTIDRUG-RESISTANCE - MICROSPECTROFLUOROMETRIC MEASUREMENTS OF P-GP-MEDIATED BODIPY-VERAPAMIL EFFLUX IN TUMOR-CELL CLUSTERS OBTAINED FROM PATIENTS BY FINE-NEEDLE BIOPSY SPECIMENS, The FASEB journal, 9(3), 1995, pp. 95-95
Authors:
THALHAMMER T
SMITH G
WOLF H
WOLF RC
BOLTZNITULESCU G
DOPPLINGER C
PENNER E
Citation: T. Thalhammer et al., CHARACTERIZATION OF ANTI-LKM-ANTIBODY TARGETS IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYP2 AND HEPATITIS-C, The FASEB journal, 9(3), 1995, pp. 146-146
Citation: T. Thalhammer et al., BILE CANALICULAR CATIONIC DYE SECRETION AS A MODEL FOR P-GLYCOPROTEINMEDIATED TRANSPORT, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(2-3), 1994, pp. 213-220
Authors:
ZACHERL J
HAMILTON G
THALHAMMER T
RIEGLER M
COSENTINI EP
ELLINGER A
BISCHOF G
SCHWEITZER M
TELEKY B
KOPERNA T
WENZL E
Citation: J. Zacherl et al., INHIBITION OF P-GLYCOPROTEIN-MEDIATED VINBLASTINE TRANSPORT ACROSS HCT-8 INTESTINAL CARCINOMA MONOLAYERS BY VERAPAMIL, CYCLOSPORINE-A AND SDZ PSC-833 IN DEPENDENCE ON EXTRACELLULAR PH, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 125-132
Authors:
STAPF V
THALHAMMER T
HUBERHUBER R
FELBERBAUER F
GAJDZIK L
GRAF J
Citation: V. Stapf et al., INHIBITION OF RHODAMINE-123 SECRETION BY CYCLOSPORINE-A AS A MODEL OFP-GLYCOPROTEIN MEDIATED TRANSPORT IN LIVER, Anticancer research, 14(2A), 1994, pp. 581-585
Authors:
THEYER G
SCHIRMBOCK M
THALHAMMER T
SHERWOOD ER
BAUMGARTNER G
HAMILTON G
Citation: G. Theyer et al., ROLE OF THE MDR-1-ENCODED MULTIPLE-DRUG RESISTANCE PHENOTYPE IN PROSTATE-CANCER CELL-LINES, The Journal of urology, 150(5), 1993, pp. 1544-1547
Authors:
THALHAMMER T
KASCHNITZ R
MITTERMAYER K
HADDAD P
GRAF J
Citation: T. Thalhammer et al., ORGANIC-SOLVENTS INCREASE MEMBRANE FLUIDITY AND AFFECT BILE-FLOW AND K-LIVER( TRANSPORT IN RAT), Biochemical pharmacology, 46(7), 1993, pp. 1207-1215